{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:53:11Z","timestamp":1790855591143,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["CRC 796"],"award-info":[{"award-number":["CRC 796"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["TP B1"],"award-info":[{"award-number":["TP B1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Interdisciplinary Center for Clinical Research Erlangen","award":["A66"],"award-info":[{"award-number":["A66"]}]},{"DOI":"10.13039\/100008672","name":"Wilhelm Sander Foundation","doi-asserted-by":"crossref","award":["2013.105.1"],"award-info":[{"award-number":["2013.105.1"]}],"id":[{"id":"10.13039\/100008672","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12967-018-1394-x","type":"journal-article","created":{"date-parts":[[2018,2,8]],"date-time":"2018-02-08T11:18:33Z","timestamp":1518088713000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Turning the tables on cytomegalovirus: targeting viral Fc receptors by CARs containing mutated CH2\u2013CH3 IgG spacer domains"],"prefix":"10.1186","volume":"16","author":[{"given":"Julia","family":"Proff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte U.","family":"Brey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Ensser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Holter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5776-4218","authenticated-orcid":false,"given":"Manfred","family":"Lehner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,8]]},"reference":[{"key":"1394_CR1","doi-asserted-by":"publisher","first-page":"e119","DOI":"10.1016\/S2352-3026(15)00289-6","volume":"3","author":"ML Green","year":"2016","unstructured":"Green ML, Leisenring W, Xie H, Mast TC, Cui Y, Sandmaier BM, et al. Cytomegalovirus viral load and mortality after haemopoietic stem cell transplantation in the era of pre-emptive therapy: a retrospective cohort study. Lancet Haematol. 2016;3:e119\u201327.","journal-title":"Lancet Haematol"},{"key":"1394_CR2","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1182\/blood-2015-11-679639","volume":"127","author":"P Teira","year":"2016","unstructured":"Teira P, Battiwalla M, Ramanathan M, Barrett AJ, Ahn KW, Chen M, et al. Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis. Blood. 2016;127:2427\u201338.","journal-title":"Blood"},{"key":"1394_CR3","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3947\/ic.2013.45.3.260","volume":"45","author":"P Ramanan","year":"2013","unstructured":"Ramanan P, Razonable RR. Cytomegalovirus infections in solid organ transplantation: a review. Infect Chemother. 2013;45:260\u201371.","journal-title":"Infect Chemother"},{"key":"1394_CR4","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1080\/14656566.2016.1199684","volume":"17","author":"L Potena","year":"2016","unstructured":"Potena L, Solidoro P, Patrucco F, Borgese L. Treatment and prevention of cytomegalovirus infection in heart and lung transplantation: an update. Expert Opin Pharmacother. 2016;17:1611\u201322.","journal-title":"Expert Opin Pharmacother"},{"key":"1394_CR5","doi-asserted-by":"publisher","first-page":"5711","DOI":"10.1182\/blood-2008-10-143560","volume":"113","author":"M Boeckh","year":"2009","unstructured":"Boeckh M, Ljungman P. How we treat cytomegalovirus in hematopoietic cell transplant recipients. Blood. 2009;113:5711\u20139.","journal-title":"Blood"},{"key":"1394_CR6","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1182\/blood-2016-06-688432","volume":"128","author":"F Chaer El","year":"2016","unstructured":"El Chaer F, Shah DP, Chemaly RF. How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients. Blood. 2016;128:2624\u201336.","journal-title":"Blood"},{"key":"1394_CR7","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/bmt.2009.258","volume":"44","author":"J Zaia","year":"2009","unstructured":"Zaia J, Baden L, Boeckh MJ, Chakrabarti S, Einsele H, Ljungman P, et al. Viral disease prevention after hematopoietic cell transplantation. Bone Marrow Transplant. 2009;44:471\u201382.","journal-title":"Bone Marrow Transplant"},{"key":"1394_CR8","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/nri.2016.38","volume":"16","author":"P Klenerman","year":"2016","unstructured":"Klenerman P, Oxenius A. T cell responses to cytomegalovirus. Nat Rev Immunol. 2016;16:367\u201377.","journal-title":"Nat Rev Immunol"},{"key":"1394_CR9","doi-asserted-by":"publisher","first-page":"793","DOI":"10.2217\/imt.15.43","volume":"7","author":"I Tzannou","year":"2015","unstructured":"Tzannou I, Leen AM. Preventing stem cell transplantation-associated viral infections using T-cell therapy. Immunotherapy. 2015;7:793\u2013810.","journal-title":"Immunotherapy"},{"key":"1394_CR10","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/tri.12659","volume":"29","author":"A Roemhild","year":"2016","unstructured":"Roemhild A, Reinke P. Virus-specific T-cell therapy in solid organ transplantation. Transpl Int. 2016;29:515\u201326.","journal-title":"Transpl Int"},{"key":"1394_CR11","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1038\/cti.2015.5","volume":"4","author":"CL Holmes-Liew","year":"2015","unstructured":"Holmes-Liew CL, Holmes M, Beagley L, Hopkins P, Chambers D, Smith C, et al. Adoptive T-cell immunotherapy for ganciclovir-resistant CMV disease after lung transplantation. Clin Transl Immunol. 2015;4:e35.","journal-title":"Clin Transl Immunol"},{"key":"1394_CR12","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1111\/ajt.13023","volume":"15","author":"N Macesic","year":"2015","unstructured":"Macesic N, Langsford D, Nicholls K, Hughes P, Gottlieb DJ, Clancy L, et al. Adoptive T cell immunotherapy for treatment of ganciclovir-resistant cytomegalovirus disease in a renal transplant recipient. Am J Transplant. 2015;15:827\u201332.","journal-title":"Am J Transplant"},{"key":"1394_CR13","doi-asserted-by":"publisher","first-page":"4083","DOI":"10.1128\/JVI.02117-09","volume":"84","author":"F Full","year":"2010","unstructured":"Full F, Lehner M, Thonn V, Goetz G, Scholz B, Kaufmann KB, et al. T cells engineered with a cytomegalovirus-specific chimeric immunoreceptor. J Virol. 2010;84:4083\u20138.","journal-title":"J Virol"},{"key":"1394_CR14","doi-asserted-by":"publisher","first-page":"e1006613","DOI":"10.1371\/journal.ppat.1006613","volume":"13","author":"RS Leibman","year":"2017","unstructured":"Leibman RS, Richardson MW, Ellebrecht CT, Maldini CR, Glover JA, Secreto AJ, et al. Supraphysiologic control over HIV-1 replication mediated by CD8 T cells expressing a re-engineered CD4-based chimeric antigen receptor. PLoS Pathog. 2017;13:e1006613.","journal-title":"PLoS Pathog"},{"key":"1394_CR15","doi-asserted-by":"publisher","first-page":"9130","DOI":"10.1038\/s41598-017-07966-3","volume":"7","author":"W Li","year":"2017","unstructured":"Li W, Wu Y, Kong D, Yang H, Wang Y, Shao J, et al. One-domain CD4 fused to human anti-CD16 antibody domain mediates effective killing of HIV-1-infected cells. Sci Rep. 2017;7:9130.","journal-title":"Sci Rep"},{"key":"1394_CR16","doi-asserted-by":"publisher","first-page":"6685","DOI":"10.1128\/JVI.00474-15","volume":"89","author":"L Liu","year":"2015","unstructured":"Liu L, Patel B, Ghanem MH, Bundoc V, Zheng Z, Morgan RA, et al. Novel CD4-based bispecific chimeric antigen receptor designed for enhanced anti-HIV potency and absence of HIV entry receptor activity. J Virol. 2015;89:6685\u201394.","journal-title":"J Virol"},{"key":"1394_CR17","doi-asserted-by":"publisher","first-page":"407","DOI":"10.2217\/imt.13.23","volume":"5","author":"S Lam","year":"2013","unstructured":"Lam S, Bollard C. T-cell therapies for HIV. Immunotherapy. 2013;5:407\u201314.","journal-title":"Immunotherapy"},{"key":"1394_CR18","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1053\/j.gastro.2007.11.002","volume":"134","author":"F Bohne","year":"2008","unstructured":"Bohne F, Chmielewski M, Ebert G, Wiegmann K, Kurschner T, Schulze A, et al. T cells redirected against hepatitis B virus surface proteins eliminate infected hepatocytes. Gastroenterology. 2008;134:239\u201347.","journal-title":"Gastroenterology"},{"key":"1394_CR19","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1136\/gutjnl-2014-308316","volume":"65","author":"GA Sautto","year":"2016","unstructured":"Sautto GA, Wisskirchen K, Clementi N, Castelli M, Diotti RA, Graf J, et al. Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein. Gut. 2016;65:512\u201323.","journal-title":"Gut"},{"key":"1394_CR20","doi-asserted-by":"publisher","first-page":"844","DOI":"10.3389\/fmicb.2016.00844","volume":"7","author":"J Proff","year":"2016","unstructured":"Proff J, Walterskirchen C, Brey C, Geyeregger R, Full F, Ensser A, et al. Cytomegalovirus-infected cells resist T cell mediated killing in an HLA-recognition independent manner. Front Microbiol. 2016;7:844.","journal-title":"Front Microbiol"},{"issue":"398\u2013413","key":"1394_CR21","first-page":"e321","volume":"171","author":"M Kadoki","year":"2017","unstructured":"Kadoki M, Patil A, Thaiss CC, Brooks DJ, Pandey S, Deep D, et al. Organism-level analysis of vaccination reveals networks of protection across tissues. Cell. 2017;171(398\u2013413):e321.","journal-title":"Cell"},{"key":"1394_CR22","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/v9010018","volume":"9","author":"Y Xia","year":"2017","unstructured":"Xia Y, Protzer U. Control of hepatitis B virus by cytokines. Viruses. 2017;9:18.","journal-title":"Viruses"},{"key":"1394_CR23","doi-asserted-by":"publisher","first-page":"6923","DOI":"10.4049\/jimmunol.180.10.6923","volume":"180","author":"AM Davis","year":"2008","unstructured":"Davis AM, Hagan KA, Matthews LA, Bajwa G, Gill MA, Gale M Jr, et al. Blockade of virus infection by human CD4+ T cells via a cytokine relay network. J Immunol. 2008;180:6923\u201332.","journal-title":"J Immunol"},{"key":"1394_CR24","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1084\/jem.188.3.577","volume":"188","author":"RM Presti","year":"1998","unstructured":"Presti RM, Pollock JL, Dal Canto AJ, O\u2019Guin AK, Virgin HWt. Interferon gamma regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessels. J Exp Med. 1998;188:577\u201388.","journal-title":"J Exp Med"},{"key":"1394_CR25","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1128\/JVI.70.4.2162-2169.1996","volume":"70","author":"JL Davignon","year":"1996","unstructured":"Davignon JL, Castanie P, Yorke JA, Gautier N, Clement D, Davrinche C. Anti-human cytomegalovirus activity of cytokines produced by CD4+ T-cell clones specifically activated by IE1 peptides in vitro. J Virol. 1996;70:2162\u20139.","journal-title":"J Virol"},{"key":"1394_CR26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1158\/2326-6066.CIR-14-0127","volume":"3","author":"M Hudecek","year":"2015","unstructured":"Hudecek M, Sommermeyer D, Kosasih PL, Silva-Benedict A, Liu L, Rader C, et al. The nonsignaling extracellular spacer domain of chimeric antigen receptors is decisive for in vivo antitumor activity. Cancer Immunol Res. 2015;3:125\u201335.","journal-title":"Cancer Immunol Res"},{"key":"1394_CR27","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/gt.2015.4","volume":"22","author":"H Almasbak","year":"2015","unstructured":"Almasbak H, Walseng E, Kristian A, Myhre MR, Suso EM, Munthe LA, et al. Inclusion of an IgG1-Fc spacer abrogates efficacy of CD19 CAR T cells in a xenograft mouse model. Gene Ther. 2015;22:391\u2013403.","journal-title":"Gene Ther"},{"key":"1394_CR28","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/mt.2014.208","volume":"23","author":"M Jonnalagadda","year":"2015","unstructured":"Jonnalagadda M, Mardiros A, Urak R, Wang X, Hoffman LJ, Bernanke A, et al. Chimeric antigen receptors with mutated IgG4 Fc spacer avoid Fc receptor binding and improve T cell persistence and antitumor efficacy. Mol Ther. 2015;23:757\u201368.","journal-title":"Mol Ther"},{"key":"1394_CR29","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1182\/blood-2014-11-612903","volume":"126","author":"H Qin","year":"2015","unstructured":"Qin H, Cho M, Haso W, Zhang L, Tasian SK, Oo HZ, et al. Eradication of B-ALL using chimeric antigen receptor-expressing T cells targeting the TSLPR oncoprotein. Blood. 2015;126:629\u201339.","journal-title":"Blood"},{"key":"1394_CR30","doi-asserted-by":"publisher","first-page":"e1253656","DOI":"10.1080\/2162402X.2016.1253656","volume":"5","author":"N Watanabe","year":"2016","unstructured":"Watanabe N, Bajgain P, Sukumaran S, Ansari S, Heslop HE, Rooney CM, et al. Fine-tuning the CAR spacer improves T-cell potency. Oncoimmunology. 2016;5:e1253656.","journal-title":"Oncoimmunology"},{"key":"1394_CR31","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s00281-014-0448-2","volume":"36","author":"E Corrales-Aguilar","year":"2014","unstructured":"Corrales-Aguilar E, Hoffmann K, Hengel H. CMV-encoded Fcgamma receptors: modulators at the interface of innate and adaptive immunity. Semin Immunopathol. 2014;36:627\u201340.","journal-title":"Semin Immunopathol"},{"key":"1394_CR32","doi-asserted-by":"publisher","first-page":"3490","DOI":"10.1128\/JVI.01476-07","volume":"82","author":"ER Sprague","year":"2008","unstructured":"Sprague ER, Reinhard H, Cheung EJ, Farley AH, Trujillo RD, Hengel H, et al. The human cytomegalovirus Fc receptor gp68 binds the Fc CH2\u2013CH3 interface of immunoglobulin G. J Virol. 2008;82:3490\u20139.","journal-title":"J Virol"},{"key":"1394_CR33","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1128\/JVI.63.5.1995-2001.1989","volume":"63","author":"U Utz","year":"1989","unstructured":"Utz U, Britt W, Vugler L, Mach M. Identification of a neutralizing epitope on glycoprotein gp58 of human cytomegalovirus. J Virol. 1989;63:1995\u20132001.","journal-title":"J Virol"},{"key":"1394_CR34","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1046\/j.1365-2249.1998.00666.x","volume":"113","author":"MJ Vugt Van","year":"1998","unstructured":"Van Vugt MJ, Van den Herik-Oudijk IE, Van de Winkel JG. FcgammaRIa-gamma-chain complexes trigger antibody-dependent cell-mediated cytotoxicity (ADCC) in CD5+ B cell\/macrophage IIA1.6 cells. Clin Exp Immunol. 1998;113:415\u201322.","journal-title":"Clin Exp Immunol"},{"key":"1394_CR35","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1038\/gt.2010.91","volume":"17","author":"A Hombach","year":"2010","unstructured":"Hombach A, Hombach AA, Abken H. Adoptive immunotherapy with genetically engineered T cells: modification of the IgG1 Fc \u2018spacer\u2019 domain in the extracellular moiety of chimeric antigen receptors avoids \u2018off-target\u2019 activation and unintended initiation of an innate immune response. Gene Ther. 2010;17:1206\u201313.","journal-title":"Gene Ther"},{"key":"1394_CR36","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1146\/annurev.immunol.19.1.65","volume":"19","author":"LG Guidotti","year":"2001","unstructured":"Guidotti LG, Chisari FV. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol. 2001;19:65\u201391.","journal-title":"Annu Rev Immunol"},{"key":"1394_CR37","doi-asserted-by":"publisher","first-page":"25482","DOI":"10.1038\/srep25482","volume":"6","author":"W Wang","year":"2016","unstructured":"Wang W, Xu L, Brandsma JH, Wang Y, Hakim MS, Zhou X, et al. Convergent transcription of interferon-stimulated genes by TNF-alpha and IFN-alpha augments antiviral activity against HCV and HEV. Sci Rep. 2016;6:25482.","journal-title":"Sci Rep"},{"key":"1394_CR38","doi-asserted-by":"publisher","first-page":"4857","DOI":"10.1016\/j.jmb.2013.08.023","volume":"425","author":"L Amsler","year":"2013","unstructured":"Amsler L, Verweij M, DeFilippis VR. The tiers and dimensions of evasion of the type I interferon response by human cytomegalovirus. J Mol Biol. 2013;425:4857\u201371.","journal-title":"J Mol Biol"},{"key":"1394_CR39","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0166-3542(88)90012-5","volume":"10","author":"EH Fennie","year":"1988","unstructured":"Fennie EH, Lie YS, Low MA, Gribling P, Anderson KP. Reduced mortality in murine cytomegalovirus infected mice following prophylactic murine interferon-gamma treatment. Antiviral Res. 1988;10:27\u201339.","journal-title":"Antiviral Res"},{"key":"1394_CR40","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1111\/tid.12285","volume":"16","author":"D Vu","year":"2014","unstructured":"Vu D, Shah T, Ansari J, Sakharkar P, Yasir Q, Naraghi R, et al. Interferon-gamma gene polymorphism +874 A\/T is associated with an increased risk of cytomegalovirus infection among Hispanic renal transplant recipients. Transpl Infect Dis. 2014;16:724\u201332.","journal-title":"Transpl Infect Dis"},{"key":"1394_CR41","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.cyto.2013.04.036","volume":"63","author":"E Bartee","year":"2013","unstructured":"Bartee E, McFadden G. Cytokine synergy: an underappreciated contributor to innate anti-viral immunity. Cytokine. 2013;63:237\u201340.","journal-title":"Cytokine"},{"issue":"566\u2013578","key":"1394_CR42","first-page":"e565","volume":"153","author":"SM Laidlaw","year":"2017","unstructured":"Laidlaw SM, Marukian S, Gilmore RH, Cashman SB, Nechyporuk-Zloy V, Rice CM, et al. Tumor necrosis factor inhibits spread of hepatitis C virus among liver cells, independent from interferons. Gastroenterology. 2017;153(566\u2013578):e565.","journal-title":"Gastroenterology"},{"issue":"Pt 1","key":"1394_CR43","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1099\/0022-1317-75-1-101","volume":"75","author":"P Lucin","year":"1994","unstructured":"Lucin P, Jonjic S, Messerle M, Polic B, Hengel H, Koszinowski UH. Late phase inhibition of murine cytomegalovirus replication by synergistic action of interferon-gamma and tumour necrosis factor. J Gen Virol. 1994;75(Pt 1):101\u201310.","journal-title":"J Gen Virol"},{"key":"1394_CR44","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1038\/mtna.2013.32","volume":"2","author":"Z Grada","year":"2013","unstructured":"Grada Z, Hegde M, Byrd T, Shaffer DR, Ghazi A, Brawley VS, et al. TanCAR: a novel bispecific chimeric antigen receptor for cancer immunotherapy. Mol Ther Nucleic Acids. 2013;2:e105.","journal-title":"Mol Ther Nucleic Acids"},{"key":"1394_CR45","doi-asserted-by":"publisher","first-page":"3036","DOI":"10.1172\/JCI83416","volume":"126","author":"M Hegde","year":"2016","unstructured":"Hegde M, Mukherjee M, Grada Z, Pignata A, Landi D, Navai SA, et al. Tandem CAR T cells targeting HER2 and IL13Ralpha2 mitigate tumor antigen escape. J Clin Invest. 2016;126:3036\u201352.","journal-title":"J Clin Invest"},{"key":"1394_CR46","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1158\/2326-6066.CIR-15-0231","volume":"4","author":"E Zah","year":"2016","unstructured":"Zah E, Lin MY, Silva-Benedict A, Jensen MC, Chen YY. T cells expressing CD19\/CD20 bispecific chimeric antigen receptors prevent antigen escape by malignant B cells. Cancer Immunol Res. 2016;4:498\u2013508.","journal-title":"Cancer Immunol Res"},{"key":"1394_CR47","first-page":"482","volume":"22","author":"UB Hansson","year":"1968","unstructured":"Hansson UB. Aggregation of human immunoglobulin G upon freezing. Acta Chem Scand. 1968;22:482\u20139.","journal-title":"Acta Chem Scand"},{"key":"1394_CR48","first-page":"461","volume":"50","author":"RN Poston","year":"1983","unstructured":"Poston RN, Morgan RS. Interactions between soluble IgG, complement and cells in lymphocyte and monocyte ADCC. Immunology. 1983;50:461\u20139.","journal-title":"Immunology"},{"key":"1394_CR49","doi-asserted-by":"publisher","first-page":"6866","DOI":"10.1038\/ncomms7866","volume":"6","author":"M Kiyoshi","year":"2015","unstructured":"Kiyoshi M, Caaveiro JM, Kawai T, Tashiro S, Ide T, Asaoka Y, et al. Structural basis for binding of human IgG1 to its high-affinity human receptor FcgammaRI. Nat Commun. 2015;6:6866.","journal-title":"Nat Commun"},{"key":"1394_CR50","doi-asserted-by":"publisher","first-page":"5327","DOI":"10.1182\/blood-2010-04-280214","volume":"116","author":"CE Poel van der","year":"2010","unstructured":"van der Poel CE, Karssemeijer RA, Boross P, van der Linden JA, Blokland M, van de Winkel JG, et al. Cytokine-induced immune complex binding to the high-affinity IgG receptor, FcgammaRI, in the presence of monomeric IgG. Blood. 2010;116:5327\u201333.","journal-title":"Blood"},{"key":"1394_CR51","doi-asserted-by":"publisher","first-page":"3262","DOI":"10.1128\/JVI.02855-15","volume":"90","author":"B Ndjamen","year":"2016","unstructured":"Ndjamen B, Joshi DS, Fraser SE, Bjorkman PJ. Characterization of antibody bipolar bridging mediated by the human cytomegalovirus Fc Receptor gp68. J Virol. 2016;90:3262\u20137.","journal-title":"J Virol"},{"key":"1394_CR52","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/0165-2478(91)90124-S","volume":"28","author":"T Nitta","year":"1991","unstructured":"Nitta T, Nakata M, Yagita H, Okumura K. Interleukin-2 activated T cells (T-LAK) express CD16 antigen and are triggered to target cell lysis by bispecific antibody. Immunol Lett. 1991;28:31\u20137.","journal-title":"Immunol Lett"},{"key":"1394_CR53","doi-asserted-by":"publisher","first-page":"5327","DOI":"10.4049\/jimmunol.180.8.5327","volume":"180","author":"B Clemenceau","year":"2008","unstructured":"Clemenceau B, Vivien R, Berthome M, Robillard N, Garand R, Gallot G, et al. Effector memory alphabeta T lymphocytes can express FcgammaRIIIa and mediate antibody-dependent cellular cytotoxicity. J Immunol. 2008;180:5327\u201334.","journal-title":"J Immunol"},{"key":"1394_CR54","doi-asserted-by":"publisher","first-page":"5127","DOI":"10.1074\/jbc.M114.599266","volume":"290","author":"AK Chauhan","year":"2015","unstructured":"Chauhan AK, Chen C, Moore TL, DiPaolo RJ. Induced expression of FcgammaRIIIa (CD16a) on CD4+ T cells triggers generation of IFN-gammahigh subset. J Biol Chem. 2015;290:5127\u201340.","journal-title":"J Biol Chem"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-018-1394-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T22:46:50Z","timestamp":1603838810000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-018-1394-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,8]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1394"],"URL":"https:\/\/doi.org\/10.1186\/s12967-018-1394-x","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,8]]},"assertion":[{"value":"14 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"26"}}